Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Zagaceta, C. Cabrera, D. Miguel, C. Cote, J. De Torres, J. Marin, C. Casanova, V. Pinto-Plata, S. Carrizo, M. Sanchez-Carpintero, J. Zulueta, B. Celli (Pamplona, Las Palmas de G.C., Zaragoza, Tenerife, Spain; Boston, Bay Pines, United States Of America). Impact of comorbidities on survival of patients with COPD according to GOLD stages. Eur Respir J 2011; 38: Suppl. 55, 2959

Member's Comments

No comment yet.

Related content which might interest you: Impact of symptomatology in patients with GOLD stage I COPD Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 The effect of changing GOLD severity stage on long-term mortality in COPD Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 Effect of COPD severity on hemodynamic responses to exercise in patients with GOLD stages I-IV Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Validation of non-spirometric predictors of COPD to the GOLD stage classification Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Relationship between quality of life and severity of COPD according to GOLD classification Source: Eur Respir J 2004; 24: Suppl. 48, 15s Year: 2004 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation Source: International Congress 2015 – Latest insights into chronic care Year: 2015 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 High prevalence of osteoporosis in COPD patients independent of GOLD stage Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010